-
Flubendazole for Autophagy Modulation: Optimized Workflows &
2026-06-04
Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) uniquely enables robust autophagy modulation workflows, from cancer cell lines to neurodegenerative disease models. This guide translates cutting-edge reference findings into actionable experimental strategies, protocol enhancements, and troubleshooting, with an emphasis on APExBIO’s high-purity, DMSO-soluble compound.
-
Dehydroabietic Acid: Dual PPAR-α/γ Agonist for Metabolic Wor
2026-06-03
Dehydroabietic acid is redefining experimental metabolic research as a natural dual PPAR-α/γ agonist, offering robust activation and workflow flexibility. Explore how its solubility, high purity, and unique pathway insights empower advanced lipid metabolism and insulin sensitivity studies.
-
Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Variant Adaptat
2026-06-03
This study introduces a high-throughput system to assess how SARS-CoV-2 spike variants interact with diverse ACE2 receptor sequences. The findings show variant-specific shifts in receptor usage, highlighting mechanisms of cross-species transmission and viral adaptation.
-
Optimizing mTOR Pathway Studies with AZD8055 (A8214)
2026-06-02
AZD8055 is a selective, ATP-competitive mTOR inhibitor that enables researchers to study the mTOR signaling pathway and its involvement in cancer cell proliferation and metabolism. It is most suitable for mechanistic studies in cellular and animal models where dual mTORC1/mTORC2 inhibition is required. AZD8055 should not be used where clinical efficacy endpoints are the primary objective due to its limited translation in late-phase trials.
-
RNA Clean and Concentrator Kit: Precision Purification for F
2026-06-02
Explore how the RNA Clean and Concentrator Kit revolutionizes RNA purification from enzymatic reactions. This in-depth guide reveals scientific insights, rigorous protocol parameters, and practical assay decisions for advanced RNA workflows.
-
TBXA2R-ERM Axis Drives Metastasis in Triple-Negative Breast
2026-06-01
Leguay et al. reveal that the thromboxane A2 receptor (TBXA2R) directly activates ERM proteins, enhancing the motility, invasion, and metastatic colonization of triple-negative breast cancer (TNBC) cells. This work uncovers a novel GPCR-mediated signaling axis driving metastasis, offering new mechanistic insights and potential targets for anti-metastatic research.
-
Topotecan in First-Line Small Cell Lung Cancer: Evidence and
2026-06-01
This article examines the innovation and clinical impact of topotecan as a first-line therapy for small cell lung cancer (SCLC), focusing on its mechanistic rationale, trial evidence, and toxicity profile. The findings highlight topotecan's role in combination regimens, manageable safety, and potential to address unmet needs in SCLC treatment.
-
Flubendazole: Applied Workflows for Autophagy Modulation Res
2026-05-31
Flubendazole, a potent benzimidazole derivative, redefines autophagy modulation in cancer biology and neurodegenerative disease models. This guide provides actionable protocol enhancements, troubleshooting strategies, and insight into leveraging its DMSO solubility for reproducible cell-based assays.
-
Dissecting Drug-Induced Proliferation Arrest and Cell Death
2026-05-30
Schwartz’s dissertation advances in vitro evaluation of anticancer drug responses by distinctly quantifying proliferation inhibition and cell death, challenging the traditional reliance on composite viability metrics. This work has significant implications for optimizing apoptosis assays and interpreting results in cancer research, particularly for mTOR inhibitors like Everolimus (RAD001).
-
Caspase 3/7 Regulate Autophagy and DNA Damage Response in Br
2026-05-29
Samarasekera et al. reveal that caspase 3 and caspase 7 facilitate cytoprotective autophagy and DNA damage response in human breast cancer cells under non-lethal stress. These findings redefine the non-apoptotic roles of caspases, opening new research avenues in stress adaptation and therapeutic targeting.
-
Dihydroartemisinin: Applied Workflows for mTOR & Malaria Res
2026-05-29
Dihydroartemisinin, a high-purity Artemisia plant extract, empowers researchers with validated workflows for probing mTOR signaling and antimalarial mechanisms. This guide dissects experimental protocols, troubleshooting strategies, and cross-domain applications for disease modeling and drug discovery.
-
MK-2206 Dihydrochloride: Deep Mechanistic Insights for Assay
2026-05-28
Explore how MK-2206 dihydrochloride enables advanced, mechanism-driven assay development through precise Akt pathway inhibition. This article provides unique protocol guidance and integrates new glycolytic signaling insights for cancer and bone biology research.
-
Redefining Apoptosis Assays: Strategic Use of Z-LEHD-FMK
2026-05-28
Z-LEHD-FMK, an irreversible caspase-9 inhibitor from APExBIO, is transforming translational research by enabling precise dissection of mitochondria-mediated apoptosis. Integrating mechanistic insights, recent melanoma research, and practical workflow strategies, this article outlines how Z-LEHD-FMK empowers advanced apoptosis assays, supports neuroprotection and cancer research, and sets a new benchmark for translational rigor.
-
Flubendazole for Autophagy Modulation in Cancer Research
2026-05-27
Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) empowers advanced autophagy modulation workflows, offering high reproducibility and mechanistic clarity in cancer biology research. This guide delivers actionable protocol enhancements, troubleshooting strategies, and leverages new insights from the tumor microenvironment to maximize Flubendazole’s impact.
-
Pharmacological Induction of Embryonic Dormancy via mTOR Inh
2026-05-27
This protocol-focused study demonstrates how reversible embryonic dormancy can be induced in vitro in mouse blastocysts, human blastoids, and pluripotent stem cells through targeted mTOR inhibition. The work offers a scalable, noninvasive alternative to traditional surgical methods, unlocking new avenues for developmental biology and reproductive technology research.